Preoperative Levosimendan. A New Way For Organoprotection"

ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)

Volume 20, 42 Issues, 2014

Download PDF Flyer

Current Pharmaceutical Design

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 62nd of 254 in Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.288
5 - Year: 3.555

Preoperative Levosimendan. A New Way For Organoprotection"

Author(s): L Guerrero Orriach Jose, A Ramirez Fernandez, P Iglesias, M Galan, A Florez, JJ Escalona, MJ Rodriguez, M Ramirez, M Rubio and J Cruz

Affiliation: Hospital Virgen de la Victoria, Campus Universitario Teatinos C.P. 29010, Malaga, Spain


Preoperative use of levosimendan in cardiac surgery patients is one of the most attractive therapeutic alternatives in subjects with left or right ventricular dysfunction. Our review explores the pharmacological bases and clinical evidence for the use of levosimendan, with the intention of making a series of recommendations regarding its use in preoperative optimization prior to cardiac surgery. We carried out a survey of 102 Spanish anesthesiologists in order to shed light on the grey areas regarding the use of this drug prior to surgery.

Our findings suggest that levosimendan is recommended for patients with severe left or right ventricular dysfunction, moderate left ventricular dysfunction in which Intra-aortic Balloon Counterpulsation (IABC) and severe pulmonary hypertension. Administration of levosimendan prior to surgical cardiac intervention without an initial bolus reduces the likelihood of complications

Keywords: Cardiac surgery, cardiac protection, levosimendan, preoperative treatment, preconditioning

Purchase Online Rights and Permissions


Article Details

Volume: 20
First Page: 1
Last Page: 8
Page Count: 8
DOI: 10.2174/1381612820666140325121452

Related Journals

Webmaster Contact: Copyright © 2014 Bentham Science